334 related articles for article (PubMed ID: 25364752)
1. Cellular prion protein and NMDA receptor modulation: protecting against excitotoxicity.
Black SA; Stys PK; Zamponi GW; Tsutsui S
Front Cell Dev Biol; 2014; 2():45. PubMed ID: 25364752
[TBL] [Abstract][Full Text] [Related]
2. Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targets.
Thellung S; Corsaro A; Dellacasagrande I; Nizzari M; Zambito M; Florio T
Front Neurosci; 2022; 16():966019. PubMed ID: 36148145
[TBL] [Abstract][Full Text] [Related]
3. The cellular prion protein mediates neurotoxic signalling of β-sheet-rich conformers independent of prion replication.
Resenberger UK; Harmeier A; Woerner AC; Goodman JL; Müller V; Krishnan R; Vabulas RM; Kretzschmar HA; Lindquist S; Hartl FU; Multhaup G; Winklhofer KF; Tatzelt J
EMBO J; 2011 May; 30(10):2057-70. PubMed ID: 21441896
[TBL] [Abstract][Full Text] [Related]
4. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
[TBL] [Abstract][Full Text] [Related]
5.
Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
[TBL] [Abstract][Full Text] [Related]
6. PrP(C) signalling in neurons: from basics to clinical challenges.
Hirsch TZ; Hernandez-Rapp J; Martin-Lannerée S; Launay JM; Mouillet-Richard S
Biochimie; 2014 Sep; 104():2-11. PubMed ID: 24952348
[TBL] [Abstract][Full Text] [Related]
7. Hijacking PrP(c)-dependent signal transduction: when prions impair Aβ clearance.
Hernandez-Rapp J; Martin-Lannerée S; Hirsch TZ; Launay JM; Mouillet-Richard S
Front Aging Neurosci; 2014; 6():25. PubMed ID: 24592237
[TBL] [Abstract][Full Text] [Related]
8. Prion protein misfolding, strains, and neurotoxicity: an update from studies on Mammalian prions.
Poggiolini I; Saverioni D; Parchi P
Int J Cell Biol; 2013; 2013():910314. PubMed ID: 24454379
[TBL] [Abstract][Full Text] [Related]
9. Profiling the culprit in Alzheimer's disease (AD): bacterial toxic proteins - Will they be significant for the aetio-pathogenesis of AD and the transmissible spongiform encephalopathies?
Schmitt HP
Med Hypotheses; 2007; 69(3):596-609. PubMed ID: 17337124
[TBL] [Abstract][Full Text] [Related]
10. What is the role of lipids in prion conversion and disease?
Alves Conceição C; Assis de Lemos G; Barros CA; Vieira TCRG
Front Mol Neurosci; 2022; 15():1032541. PubMed ID: 36704327
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective role of PrPC against kainate-induced epileptic seizures and cell death depends on the modulation of JNK3 activation by GluR6/7-PSD-95 binding.
Carulla P; Bribián A; Rangel A; Gavín R; Ferrer I; Caelles C; Del Río JA; Llorens F
Mol Biol Cell; 2011 Sep; 22(17):3041-54. PubMed ID: 21757544
[TBL] [Abstract][Full Text] [Related]
12. The Biological Function of the Prion Protein: A Cell Surface Scaffold of Signaling Modules.
Linden R
Front Mol Neurosci; 2017; 10():77. PubMed ID: 28373833
[TBL] [Abstract][Full Text] [Related]
13. Copper-dependent regulation of NMDA receptors by cellular prion protein: implications for neurodegenerative disorders.
Stys PK; You H; Zamponi GW
J Physiol; 2012 Mar; 590(6):1357-68. PubMed ID: 22310309
[TBL] [Abstract][Full Text] [Related]
14. Metal Dyshomeostasis and Their Pathological Role in Prion and Prion-Like Diseases: The Basis for a Nutritional Approach.
Toni M; Massimino ML; De Mario A; Angiulli E; Spisni E
Front Neurosci; 2017; 11():3. PubMed ID: 28154522
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
16. Tau Protein as a New Regulator of Cellular Prion Protein Transcription.
Lidón L; Vergara C; Ferrer I; Hernández F; Ávila J; Del Rio JA; Gavín R
Mol Neurobiol; 2020 Oct; 57(10):4170-4186. PubMed ID: 32683652
[TBL] [Abstract][Full Text] [Related]
17. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
Moreno JA; Telling GC
Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
[TBL] [Abstract][Full Text] [Related]
18. The Cellular Prion Protein-ROCK Connection: Contribution to Neuronal Homeostasis and Neurodegenerative Diseases.
Schneider B; Baudry A; Pietri M; Alleaume-Butaux A; Bizingre C; Nioche P; Kellermann O; Launay JM
Front Cell Neurosci; 2021; 15():660683. PubMed ID: 33912016
[TBL] [Abstract][Full Text] [Related]
19. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors.
Khosravani H; Zhang Y; Tsutsui S; Hameed S; Altier C; Hamid J; Chen L; Villemaire M; Ali Z; Jirik FR; Zamponi GW
J Cell Biol; 2008 May; 181(3):551-65. PubMed ID: 18443219
[TBL] [Abstract][Full Text] [Related]
20. Rescue of Transgenic Alzheimer's Pathophysiology by Polymeric Cellular Prion Protein Antagonists.
Gunther EC; Smith LM; Kostylev MA; Cox TO; Kaufman AC; Lee S; Folta-Stogniew E; Maynard GD; Um JW; Stagi M; Heiss JK; Stoner A; Noble GP; Takahashi H; Haas LT; Schneekloth JS; Merkel J; Teran C; Naderi ZK; Supattapone S; Strittmatter SM
Cell Rep; 2019 Jan; 26(1):145-158.e8. PubMed ID: 30605671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
